Please assess the completion status of the following clinical trial:

Trial Title: Inpatient Versus Outpatient Cervical Ripening

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnancies at least 37 weeks' gestation, undergoing induction of labor, with an unfavorable cervix, defined as a Bishop score ≤ 6~* The fetus must be in the cephalic presentation~* Indications for induction of labor include, but are not limited to, the following:~  * Elective induction of labor at 39 weeks' gestation~ * Intrauterine growth restriction~ * Chronic hypertension~ * Diabetes~ * Gestational diabetes~ * Prior stillbirth~ * Other medical indications for induction of labor, as deemed appropriate by the obstetric provider, such as Systemic Lupus Erythematosus, Cholestasis of Pregnancy etc.~Exclusion Criteria:~* Gestational hypertension~* Preeclampsia~* Non-reassuring fetal testing~* Multi-fetal gestation~* Oligohydramnios~* Fetal anomaly~* Less than 37 weeks~* Bishop score \> 6~* Ruptured membranes~* Contraindication to vaginal delivery including: active Herpes lesion, HIV VL \>1000 copies/mL, placenta previa, vasa previa, breech presentation, prior classical cesarean section or transfundal myomectomy~* Poor access to telephone or transportation~* Latex allergy~* Any other condition for which the managing physician or investigator deem outpatient management inappropriate.~* Currently participating in another clinical trial

- Gender: FEMALE
- Minimum Age: 14 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Inpatient Foley catheter (Type: ACTIVE_COMPARATOR): Subjects will be admitted to a room on labor and delivery and will be monitored with the external fetal monitor (EFM) and tocometer (a device to monitor contractions). If she is contracting less than every 2 minutes, intravenous (IV) Pitocin will be started at 2 milliunits/minute and increased per hospital protocol. While on pitocin, she will remain on continuous EFM and tocometer. She will also be kept on a clear liquid diet with intravenous fluids per standard protocol. If the Foley catheter has not been expulsed in 24 hours, it will be removed. After expulsion or removal of the Foley catheter, induction may proceed as deemed clinically appropriate by the managing physician. No further cervical ripening will be performed after the Foley catheter is expulsed/removed, or after 24 hours.
- Outpatient Foley catheter (Type: EXPERIMENTAL): Subjects are asked to return to the hospital \~12 hours after placement. Subjects are to return to the hospital if they develop heavy vaginal bleeding, decreased fetal movement, rupture of membranes, or increasingly painful or frequent contractions requiring an epidural or pain relief. Once admitted, subjects will be evaluated for expulsion of the catheter. If the catheter is in place IV Pitocin will be started. If the catheter has been expulsed, the induction will proceed as deemed clinically appropriate. After 24 hours, if the Foley catheter is still in the cervix it will be removed and the induction will proceed as deemed clinically appropriate.

Based on this trial design, predict the completion outcome and termination type (if applicable).